Drug-drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
- PMID: 30500876
- PMCID: PMC6514818
- DOI: 10.1093/eurheartj/ehy780
Drug-drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
Comment in
-
Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants.Eur Heart J. 2019 May 14;40(19):1569-1570. doi: 10.1093/eurheartj/ehy784. Eur Heart J. 2019. PMID: 30500883 No abstract available.
Comment on
-
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136. Eur Heart J. 2018. PMID: 29562325
References
-
- Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H; ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018;39:1330–1393. - PubMed
-
- Levy RH, Ragueneau-Majlessi I, Baltes E.. Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers. Epilepsy Res 2001;46:93–99. - PubMed
-
- Hole K, Wollmann BM, Nguyen C, Haslemo T, Molden E.. Comparison of CYP3A4-inducing capacity of enzyme-inducing antiepileptic drugs using 4β-hydroxycholesterol as biomarker. Ther Drug Monit 2018;40:463–468. - PubMed
-
- Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W.. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacol 2007;52:333–346. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources